Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2019HeliyonOpen Access

In vitro inhibitory activity of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 alone or in combination against bacterial and Candida reference strains and clinical isolates

View Full Paper
Ask AI
Bookmark
Share

Authors

RIRosanna InturriFidia Farmaceutici (Italy)LTLaura TrovatoUniversity of CataniaGVGiovanni Li VoltiUniversity of Catania

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Inturri et al. (2019) studied this question.

synapsesocial.com/papers/6a282f81fa5cfd7b5922ac2bhttps://doi.org/10.1016/j.heliyon.2019.e02891
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Probiotics and Its Functionally Valuable Products—A Review2013 · 219 citations
  2. 2Ubiquity of R Factor-Mediated Antibiotic Resistance in the Healthy Population1977 · 6 citations
  3. 3A Microplate Growth Inhibition Assay for Screening Bacteriocins against Listeria monocytogenes to Differentiate Their Mode-of-Action2015 · 55 citations
  4. 4Nonpathogenic Lactobacillus rhamnosus activates the inflammasome and antiviral responses in human macrophages2012 · 56 citations